Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

被引:55
|
作者
Wen, Shi-Rong [2 ]
Liu, Guo-Jun [2 ]
Feng, Ren-Nan [3 ]
Gong, Feng-Chao [2 ]
Zhong, Hua [2 ]
Duan, Shu-Rong [2 ]
Bi, Sheng [1 ,2 ]
机构
[1] Harbin Med Coll, Cent Lab, Affiliated Hosp 1, Harbin 150001, Peoples R China
[2] Harbin Med Coll, Dept Neurol, Affiliated Hosp 1, Harbin 150001, Peoples R China
[3] Harbin Med Coll, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin 150001, Peoples R China
关键词
Osteopontin; IL-23; Multiple sclerosis; DENDRITIC CELLS; MESSENGER-RNA; PATHOGENESIS; EXPRESSION; CORRELATE; DISEASE;
D O I
10.1016/j.jneuroim.2011.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) and interleukin-23 (IL-23) are pro-inflammatory cytokines proposed to play central roles to the development of multiple sclerosis (MS). The aim of this study was to evaluate levels of OPN, IL-23 and other inflammatory cytokines and investigate their relationships in serum and cerebrospinal fluid (CSF) in patients with MS. Fifty one MS patients and 48 patients with non-inflammatory neurological diseases (NIND) were recruited from clinic. The levels of OPN, IL-23, IL-17, IL-6, and tumor necrosis factor-alpha (TNF-alpha) in serum and CSF were determined in each participant. Compared with NIND group, MS patients had significantly elevated levels of OPN, IL-23, IL-17 and TNF-alpha in CSF, and elevated levels of IL-23, IL-17 and TNF-alpha in serum (All P<0.001). In MS patients, OPN and IL-23 were positively correlated with IL-17 (r = 0.302, P=0.019; r = 0.417, P=0.001, respectively); and IL-23 was positively correlated with EDSS (r = 0.329, P=0.019). Both OPN and IL-23 may play pivotal role in development of MS and might be specific markers and therapeutic targets for MS. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [41] Serum IL-27, IL-23 and IL-35 Levels in Neuromyelitis Optica Spectrum Disorders with Aquaporin-4 and Multiple Sclerosis
    Idiman, Egemen
    Kaya, D.
    Hasankoyoglu, O.
    Keskin, A. O.
    Tasdemir, N.
    Altun, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 409 - 409
  • [42] SERUM AND CEREBROSPINAL FLUID IMMUNOGLOBULINS IN MULTIPLE SCLEROSIS
    KOLAR, OJ
    ROSS, AT
    HERMAN, JT
    NEUROLOGY, 1970, 20 (11) : 1052 - &
  • [43] Increased EBV Reactivation in the Cerebrospinal Fluid of Patients with Early Multiple Sclerosis
    Jaquiery, Emilie
    Jilek, Samantha
    Schluep, Myriam
    Meylan, Pascal
    Lysandropoulos, Andreas
    Pantaleo, Giuseppe
    Du Pasquier, Renaud A.
    JOURNAL OF NEUROVIROLOGY, 2009, 15 : 38 - 38
  • [44] Serum and cerebrospinal fluid angiotensin II levels in Optic Neuritis and Multiple Sclerosis
    Degn, Vinther Matilda
    Rhorbjorn, Jensen Lars
    Jette, Frederiksen
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 11 - 11
  • [45] The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis
    Keles, MS
    Taysi, S
    Aksoy, H
    Sen, N
    Polat, F
    Akcay, F
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (09) : 827 - 829
  • [46] VITAMIN B12 LEVELS IN SERUM + CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS
    SIMPSON, CA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1964, 27 (02): : 174 - +
  • [47] Serum and cerebrospinal fluid levels of neural cell adhesion molecule in multiple sclerosis
    Massaro, A. R.
    Carbone, G.
    MULTIPLE SCLEROSIS, 2006, 12 : S140 - S140
  • [48] Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis
    Boylan, MT
    Crockard, AD
    McDonnell, GV
    McMillan, SA
    Hawkins, SA
    IMMUNOLOGY LETTERS, 2001, 78 (03) : 183 - 187
  • [49] Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate
    Barac, Ioana S.
    Vacaras, Vitalie
    Iancu, Mihaela
    Muresanu, Dafin F.
    Procopciuc, Lucia M.
    HELIYON, 2023, 9 (06)
  • [50] Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis
    Ruggeri, Rosaria Maddalena
    Saitta, Salvatore
    Cristani, Mariateresa
    Giovinazzo, Salvatore
    Tigano, Valeria
    Trimarchi, Francesco
    Benvenga, Salvatore
    Gangemi, Sebastiano
    ENDOCRINE JOURNAL, 2014, 61 (04) : 359 - 363